All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Completed, but no date, and reported results | 2017-000347-41 | Safety of extended use of the weekly oral docetaxel formulation ModraDoc006/r in patients with advanced solid tumours Veiligheid van voortgaand gebruik van de wekelijkse orale docetaxel formulerin... | bad-data | |
Listed as ongoing, but also has a completion date and reported results | 2018-003249-41 | A multicentre phase IIa study to evaluate the efficacy and tolerability of ModraDoc006/r in patients with recurrent or metastatic HER-2 negative breast cancer, suitable for treatment with a taxane | 2020-11-09 | bad-data |
Reported results | 2019-000582-21 | A multicentre Phase IIb trial to evaluate the efficacy and tolerability of ModraDoc006/r in subjects with metastatic Castration Resistant Prostate Cancer (mCRPC), suitable for treatment with a taxane. | 2021-11-29 | due-trials |